Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Johnson & Johnson is reaching out beyond its lead creative agency on Tylenol, Interpublic Group’s Deutsch in New York, for new ideas on the brand, according to sources.
Executives from J&J’s McNeil Consumer Healthcare division are meeting with agencies this week, and are expected to make a decision by early February, per sources.
Deutsch is believed to be defending the business against as many as three agencies, said sources.
The company spent about $100 million in measured media supporting Tylenol during the first three-quarters of 2009, according to Nielsen.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in